Depressive Disorder, Treatment-ResistantAntidepressive AgentsDepressive Disorder, MajorElectroconvulsive TherapySubstance-Related DisordersSubstance Abuse Treatment CentersDepressive DisorderResidential TreatmentEating DisordersAntidepressive Agents, TricyclicDrug ResistanceAntidepressive Agents, Second-GenerationFluoxetineSerotonin Uptake InhibitorsTreatment OutcomeCitalopramAntipsychotic AgentsSertralineDesipramineCognitive TherapyImipramineCyclohexanolsDepressionBipolar DisorderPsychiatric Status Rating ScalesAnxiety DisordersNortriptylineParoxetineMood DisordersPhenelzineTranylcypromineMianserinDiagnostic and Statistical Manual of Mental DisordersAmitriptylineMental DisordersAdrenergic Uptake InhibitorsMonoamine Oxidase InhibitorsSerotonin Plasma Membrane Transport ProteinsSwimmingDysthymic DisorderBrain-Derived Neurotrophic FactorBrainComorbidityPersonality InventorySuicideAnhedoniaStress, PsychologicalPsychotherapyBupropionBehavior, AnimalHelplessness, LearnedHippocampusElectroshockSeverity of Illness IndexSerotoninAnxietyReceptor, Serotonin, 5-HT1AAffectAnalysis of VarianceFluvoxamineStress Disorders, Post-TraumaticTime FactorsAttention Deficit Disorder with HyperactivityInterview, PsychologicalObsessive-Compulsive DisorderZimeldineRats, Sprague-DawleyGyrus CinguliPhobic DisordersRisk FactorsHypothalamo-Hypophyseal SystemPrefrontal CortexClomipramineTupaiaReceptors, Serotonin, 5-HT1Biogenic MonoaminesCognition DisordersPsychotic DisordersSuicide, AttemptedPharmacogeneticsDouble-Blind MethodBuspironePituitary-Adrenal SystemQuestionnairesRecurrenceEmotionsReceptors, SerotoninAmygdalaPsychotropic DrugsMagnetic Resonance ImagingFollow-Up StudiesFrontal LobeSomatoform DisordersPrevalenceDisease Models, AnimalCorticosteroneBorderline Personality DisorderAffective Disorders, PsychoticAutistic DisorderDrug Therapy, Combination